Cargando…
Lipid-Based Nanocarriers in Renal RNA Therapy
Kidney disease is a multifactorial problem, with a growing prevalence and an increasing global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) is the 12th leading cause of death, it is no surprise that CKD remains a public health problem that requires urgent atten...
Autores principales: | Su, Chi-Ting, See, Daniel H. W., Huang, Jenq-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869454/ https://www.ncbi.nlm.nih.gov/pubmed/35203492 http://dx.doi.org/10.3390/biomedicines10020283 |
Ejemplares similares
-
Lipid-Based Nanocarriers for RNA Delivery
por: Xue, Hui Yi, et al.
Publicado: (2015) -
Exosomes as Natural Nanocarriers for RNA-Based Therapy and Prophylaxis
por: Gorshkov, Andrey, et al.
Publicado: (2022) -
Use of Microfluidics to Prepare Lipid-Based Nanocarriers
por: Vogelaar, Alicia, et al.
Publicado: (2023) -
Bioinspired Lipid Nanocarriers for RNA Delivery
por: Golubovic, Alex, et al.
Publicado: (2023) -
Chitosan Based MicroRNA Nanocarriers
por: Genedy, Hussein H., et al.
Publicado: (2022)